Results 261 to 270 of about 2,327,584 (298)
Some of the next articles are maybe not open access.
Management of brain metastases
Seminars in Oncology, 2004Patients with brain metastases have a generally poor outcome with a median survival after diagnosis of approximately 4 months. Management of brain metastases involves symptomatic treatment and definitive therapy, with the goal of stabilizing and improving neurologic function and survival. Traditional and novel therapies, including whole-brain radiation
Kristin A, Bradley, Minesh P, Mehta
openaire +4 more sources
Brain Metastases and Microenvironment
2021The formidable advances in cancer treatment have led to remarkable improvements in patient's survival, so that the major concern shifted from primary tumors to metastatic disease. Brain metastases represent a life-threatening condition with a poor prognosis due to the lack of reliable biomarkers that preclude their timely identification and to the ...
openaire +2 more sources
Distribution of Brain Metastases
Archives of Neurology, 1988The number and site of brain metastases were identified on the computed tomographic scans of 288 patients. There was one brain metastasis in 49%, two in 21%, three in 13%, four in 6%, and five or more in 11% of scans. In patients with one metastasis, the posterior fossa was involved in 50% of patients when the primary tumor was pelvic (prostate or ...
J Y, Delattre +3 more
openaire +2 more sources
2007
It is estimated that 170,000 new cases of metastatic brain tumor are diagnosed in the United States each year [1]. As our population ages and oncologists are better able to achieve control of systemic disease, it is likely that the incidence of intracranial metastatatic disease will continue to increase.
Sunit, Das +2 more
openaire +2 more sources
It is estimated that 170,000 new cases of metastatic brain tumor are diagnosed in the United States each year [1]. As our population ages and oncologists are better able to achieve control of systemic disease, it is likely that the incidence of intracranial metastatatic disease will continue to increase.
Sunit, Das +2 more
openaire +2 more sources
Management of brain metastases
Journal of Neurology, 2002Brain metastases occur in 20-40% of patients with cancer and their frequency has increased over time. Lung, breast and skin (melanoma) are the commonest sources of brain metastases, and in up to 15% of patients the primary site remains unknown. After the introduction of MRI, multiple lesions have outnumbered single lesions. Contrast-enhanced MRI is the
SOFFIETTI, Riccardo +2 more
openaire +2 more sources
Chemoprevention for Brain Metastases
Current Oncology Reports, 2011With the advent of effective therapies for systemic disease control, the prevalence of brain metastases (BMs) has been increasing. Relapses in the brain are a major barrier to cure in many patients with lung cancer and other malignancies. Effective agents are needed to prophylactically treat micrometastatic disease in patients at high risk for BMs ...
Van A, Trinh, Wen-Jen, Hwu
openaire +2 more sources
The Journal of Pediatrics, 1983
We reviewed the records of 31 children under the age of 21 years with parenchymal brain metastases diagnosed by CT scan (13 patients) or necropsy (18). Brain metastases were found in 18 of 139 (13%) children with solid tumors in whom complete postmortem examinations were done.
F, Graus, R W, Walker, J C, Allen
openaire +2 more sources
We reviewed the records of 31 children under the age of 21 years with parenchymal brain metastases diagnosed by CT scan (13 patients) or necropsy (18). Brain metastases were found in 18 of 139 (13%) children with solid tumors in whom complete postmortem examinations were done.
F, Graus, R W, Walker, J C, Allen
openaire +2 more sources
Journal of Neuroimaging, 2011
The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Sasan, Karimi +4 more
openaire +2 more sources
The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Sasan, Karimi +4 more
openaire +2 more sources
Journal of Clinical Oncology, 2006
Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients ...
Michael A, Vogelbaum, John H, Suh
openaire +2 more sources
Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients ...
Michael A, Vogelbaum, John H, Suh
openaire +2 more sources
Brain metastases reirradiation
Cancer/RadiothérapieThe advances in cancer screening and therapies have allowed the improvement of metastatic patients' survival, including those with brain metastases. This led to a substantial shift in brain metastases patients' management for whom whole-brain radiation therapy, formerly widely used, has given way to a more focused management in which single- or ...
Claire, Petit, Agnès, Tallet
openaire +2 more sources

